CohBar Expands Its Scientific Staff With the Addition of Kent Grindstaff

MENLO PARK, CA – May 1, 2015 – CohBar, Inc., an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, today announced it has hired Kent Grindstaff as its Vice President of Biology. During his career, Mr. Grindstaff has held increasingly senior roles in the industry most recently as VP of Global Operations at SOLVO Biotechnology. An expert in the area of assay development, Mr. Grindstaff will design and manage the day to day development, validation, and application of new in vitro screens that can test the activity of our optimized compounds in his role as VP of Biology.